PDGFRB and myeloid sarcoma: An autopsy report on MS patients showed that with the progression of the MS disease process, the expression of PDGFRβ, a marker of pericytes, was upregulated in areas with brain lesions, suggesting a link between pericytes and the progression of MS [113].